Compare
Medpace vs Thermo Fisher Scientific (MEDP vs TMO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Medpace (MEDP) returned +9.1% and Thermo Fisher Scientific (TMO) +22.4%; so far this year the figures are +16.3% and +19.9%.
Thermo Fisher Scientific is the larger company by market value, about 14.1 times the size of Medpace.
On trailing earnings, MEDP trades at 36.3 times and TMO at 36.6 times.
Revenue grew +20.4% at MEDP and +8.3% at TMO over the last year.
MEDP pays no dividend. TMO yields 0.26%.
Data as of the latest close. Not investment advice.
Relative performance
| MEDP | TMO | |
|---|---|---|
| Price | $653.11 | $694.76 |
| 1-day | +2.86% | +2.63% |
| YTD | +16.28% | +19.90% |
| 1 year | +9.07% | +22.39% |
| 3 years | +159.57% | +57.50% |
| Market cap | $18.3B | $257.4B |
| P/E | 36.3 | 36.6 |
| P/S | 6.44 | 5.44 |
| P/B | 31.23 | 4.70 |
| Revenue growth | +20.40% | +8.30% |
| EPS growth | +25.90% | +9.50% |
| Gross margin % | — | 25.2 |
| Net margin % | 18.2 | 14.9 |
| ROE % | 88.5 | 12.9 |
| Debt / equity | 0.00 | 0.79 |
| FCF yield % | 3.7 | 3.0 |
| Dividend yield % | — | 0.26 |
| Beta | 0.69 | 0.67 |
| RSI (14) | 53.5 | 54.7 |
| Technical rating |